[4-(1-Piperidin-1-ylethyl)phenyl]boronic acid, 95.0%, 10g

1-(AZETIDIN-1-YL)-3-CHLOROPROPAN-1-ONE, 95.0%, 500mg

3-Methyl-[1,2,4]triazolo[4,3-a]pyridine, 95.0%, 5g

7-Bromo-1-methyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one, 95%, 5g

N''-amino-N-methylguanidine hydroiodide, 5g

3,5-Dibromo-2-methylthiophene, 95.0%, 25g

6-(1H-Imidazol-1-yl)nicotinic acid, 97.0%, 250mg

3-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-5-AMINE, 95%, 100mg

4-Methyl-3,4-dihydro-2H-1,4-benzoxazin-6-amine, 95.0%, 100mg

3-Methylcoumarilic acid potassium salt, 98.0%, 1g

Ácido octanoico, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

Bis(4-(naphthalen-2-yl)phenyl)amine, 97%, 5g

3-(4-Methylpiperazin-1-yl)benzaldehyde, 95.0%, 100mg